|
|
41
|
2451AQ
|
LOPERAMIDE 2MG CAP (TEV)
|
COL
|
2024-12-17
|
2026-03-31
|
A
|
30'S
|
30
|
4.57
|
|
2024-11-26
|
|
|
41
|
0012FP
|
LORATADINE 10MG TAB (MCP)
|
AHI
|
2024-12-28
|
2026-03-31
|
A
|
10X10
|
14
|
7.85
|
|
2024-12-27
|
|
|
40
|
0013PF
|
LORATADINE 1MG/ML SYRUP (HEA/ATB)
|
ATB
|
2022-12-07
|
2024-03-31
|
A
|
100 ML
|
|
3.13
|
Change Local Agent
|
2022-11-25
|
|
|
40
|
4622U
|
LORAZEPAM 2MG/ML INJ (FSB/ATB)
|
ATB
|
2022-05-27
|
2024-03-31
|
B
|
1ML VIAL
|
0
|
4.02
|
Price Change
|
2022-05-27
|
|
|
40
|
4622S
|
LORAZEPAM 2MG/ML INJ (KWA/ATB)
|
ATB
|
2022-04-01
|
2024-03-31
|
B
|
10X1ML
|
0
|
38.19
|
|
2022-03-30
|
|
|
40
|
A501EK
|
LOSARTAN 50MG TAB (HEA/ATB)
|
ATB
|
2022-12-07
|
2024-03-31
|
A
|
30'S
|
|
2.15
|
Change Local Agent
|
2022-11-25
|
|
|
40
|
A531AH
|
LOUTEN EMULSION 0.005% EYE DR (LPO/COL) LATAN
|
COL
|
2022-04-01
|
2024-03-31
|
A
|
2.5ML
|
1
|
9.08
|
|
2022-02-18
|
|
|
41
|
19415
|
MEDI-TEST COMBI 10 STRP (SCN) DIAGNOSTIC URINE (B)
|
PHA
|
2024-04-01
|
2026-03-31
|
B
|
100'S
|
0
|
25.1
|
|
2023-10-05
|
|
|
40
|
19415
|
MEDI-TEST COMBI 10 STRP (SCN/PHA) DIAGNOSTIC URINE
|
PHA
|
2022-07-19
|
2024-03-31
|
B
|
100'S
|
0
|
20.44
|
Price Change
|
2022-07-18
|
|
|
40
|
0211Y
|
MEROPENEM 500MG INJ (ABB/PHA) (BQ)
|
PHA
|
2022-04-01
|
2023-03-31
|
BQ
|
500MG VIAL
|
|
11.5
|
Delete from contract
|
2023-03-02
|
|
|
40
|
1351E
|
METAMIZOL 500MG TAB (HEA/ATB)
|
ATB
|
2022-12-07
|
2024-03-31
|
A
|
250'S
|
|
17.53
|
Change Local Agent
|
2022-11-25
|
|
|
40
|
28439
|
METFORMIN 1G TAB (APL/AHI)
|
AHI
|
2022-04-01
|
2024-03-31
|
A
|
100'S
|
90
|
10.76
|
Amend Protocol Quantity
|
2022-08-15
|
|
|
40
|
2841BX
|
METFORMIN XR
|
ATB
|
2022-12-07
|
2024-03-31
|
A
|
100'S
|
120
|
7.48
|
ADD AS CAT A BENEFIT
|
2022-12-07
|
|
|
40
|
2841BX
|
METFORMIN XR 500MG TAB (HEA/ATB)
|
ATB
|
2022-12-07
|
2024-03-31
|
A
|
10X10
|
|
7.48
|
Change Local Agent
|
2022-11-25
|
|
|
40
|
2841BM
|
METFORMIN XR 500MG TAB (HEA/RXP)
|
RXP
|
2022-04-01
|
2022-12-07
|
A
|
10X10
|
120
|
7.48
|
DEL
|
2022-12-07
|
|
|
40
|
0631Y
|
METHOTREXATE 2.5MG TAB (FSB/ATB)
|
ATB
|
2022-04-01
|
2022-09-30
|
A
|
100'S
|
32
|
7.48
|
|
2022-03-30
|
|
|
40
|
4121B
|
METHYLPREDNISOLONE SODIUM SUCCINATE 500MG INJ (KWA/ATB)
|
ATB
|
2022-04-01
|
2022-09-30
|
B
|
500MG VIAL
|
0
|
15.36
|
|
2022-03-30
|
|
|
40
|
7621BE
|
MIA 3MG D/0.02MG EE TAB (ABB/PHA) DROSP/EE (C)
|
PHA
|
2022-04-01
|
2023-03-31
|
C
|
28'S
|
|
19.52
|
Delete from contract
|
2023-03-07
|
|
|
40
|
7621BD
|
MIA 3MG D/0.03MG EE TAB (ABB/PHA) DROSP/EE (C)
|
PHA
|
2022-04-01
|
2023-03-31
|
C
|
28'S
|
|
21.34
|
Delete from contract
|
2023-03-02
|
|
|
41
|
52354
|
MICOGEL 2% GEL (ARP) MICONAZOLE
|
AHI
|
2024-04-01
|
2026-03-31
|
B
|
15G
|
2
|
5.36
|
|
2023-11-21
|